House Dem chairmen to meet with progressives amid drug pricing divisions

House Dem chairmen to meet with progressives amid drug pricing divisions
© Greg Nash

Two key House Democratic committee chairmen will meet with progressive House Democrats next week amid divisions in the party over how to craft their signature legislation to lower drug prices, according to House Democratic aides.

House Energy and Commerce Committee Chairman Frank Pallone Jr.Frank Joseph PallonePharma execs say FDA will not lower standards for coronavirus vaccine Dem chairmen urge CMS to prevent nursing homes from seizing stimulus payments Federal watchdog finds cybersecurity vulnerabilities in FCC systems MORE (D-N.J.) and House Ways and Means Committee Chairman Richard NealRichard Edmund NealConservatives urge Trump to take unilateral action to suspend payroll tax collection Treasury to conduct policy review of tax-exempt status for universities after Trump tweets Stimulus checks debate now focuses on size, eligibility MORE (D-Mass.) will meet with members of the Congressional Progressive Caucus next week to discuss legislation to allow Medicare to negotiate drug prices.

Lawmakers in the Progressive Caucus have been pushing for what they view as a bill that is tougher on drug companies, from Rep. Lloyd DoggettLloyd Alton DoggettOvernight Health Care: Fauci says family has faced threats | Moderna to charge to a dose for its vaccine | NYC adding checkpoints to enforce quarantine GOP plan would boost deduction for business meals Gilead sets price for five-day coronavirus treatment at ,120 MORE (D-Texas), which would strip a company of its monopoly on a drug if it refused to negotiate the price with the government.

ADVERTISEMENT

But Speaker Nancy PelosiNancy PelosiGOP chairmen hit back at accusation they are spreading disinformation with Biden probe Negotiators remain far apart on coronavirus deal as deadline looms Top federal official says more details coming on foreign election interference MORE’s (D-Calif.) office is working on a competing plan that would use an outside arbitrator to set the price if negotiations fell through, a system that some progressives view as too weak.

The meeting could allow the powerful chairmen to discuss the differences of opinion on drafting the legislation with the progressive lawmakers.

A House Democratic aide said the chairmen would not be presenting a plan at the meeting and instead would be listening to gather input from lawmakers about how to craft legislation for Medicare to negotiate drug prices.

Lowering drug prices is one of House Democrats’ top priorities, one that Pelosi frequently touts as part of the party’s focus on kitchen table issues. But Democrats have yet to unveil their signature legislation on the topic, leading some progressives to grow impatient about the pace of action on a core priority.

Complicating the situation, Pelosi’s office is also in talks with the White House about lowering drug prices, something that some progressives also view with skepticism.

Pelosi expressed optimism about reaching a deal with President TrumpDonald John TrumpLincoln Project ad dubs Jared Kushner the 'Secretary of Failure' Pence: Chief Justice Roberts 'has been a disappointment to conservatives' Twitter bans Trump campaign until it deletes tweet with COVID-19 misinformation MORE on lowering drug prices in an interview with Time magazine on Tuesday.

“In our conversations, [at a] staff level, and my conversations with him I think we can find a path do that,” Pelosi said.